Vivo Capital, LLC Geron Corp Transaction History
Vivo Capital, LLC
- $512 Million
- Q4 2024
A detailed history of Vivo Capital, LLC transactions in Geron Corp stock. As of the latest transaction made, Vivo Capital, LLC holds 27,225,292 shares of GERN stock, worth $69.7 Million. This represents 18.81% of its overall portfolio holdings.
Number of Shares
27,225,292
Previous 27,225,292
-0.0%
Holding current value
$69.7 Million
Previous $124 Million
22.03%
% of portfolio
18.81%
Previous 18.09%
Shares
5 transactions
Others Institutions Holding GERN
# of Institutions
304Shares Held
460MCall Options Held
1.44MPut Options Held
687K-
Black Rock Inc. New York, NY46.6MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$85.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$76.8 Million1.72% of portfolio
-
State Street Corp Boston, MA27.2MShares$69.5 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X027.1MShares$69.3 Million0.05% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $967M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...